NASDAQ: PAVM - PAVmed Inc.

Altı ay boyunca karlılık: -39.02%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı PAVmed Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında PAVmed Inc.

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay.

daha fazla ayrıntı
Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2016-04-28
ISIN US70387R1068
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.pavmed.com
Цена ао 0.815
Günlük fiyat değişimi: -2.34% (0.768)
Haftalık fiyat değişimi: -7.41% (0.81)
Aylık fiyat değişimi: +5.63% (0.71)
3 ayda fiyat değişimi: +15.74% (0.648)
Altı ayda fiyat değişimi: -39.02% (1.23)
Yıllık fiyat değişimi: -64.95% (2.14)
3 yılda fiyat değişimi: -57.39% (1.76)
5 yılda fiyat değişimi: -72.38% (2.715)
Yılbaşından bu yana fiyat değişimi: +19.52% (0.6275)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 0.014 10
P/BV -0.006 0
P/E 0.0013 10
EV/EBITDA -0.6905 0
Toplam: 7.38

Yeterlik

İsim Anlam Seviye
ROA, % 208.29 10
ROE, % -2508.29 0
Toplam: 5

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA -0.7162 10
Toplam: 9.4

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 598900 10
karlılık Ebitda, % 185262.5 10
karlılık EPS, % -67741.35 0
Toplam: 6
Daha fazla ayrıntı

Kurumlar Hacim Paylaşmak, %
Vanguard Group Inc 302606 3.3
First Manhattan Company 200000 2.18
Blackrock Inc. 74922 0.82
Geode Capital Management, LLC 55078 0.6
Susquehanna International Group, LLP 22561 0.25
Valeo Financial Advisors, LLC 21129 0.23
State Street Corporation 20981 0.23
Northern Trust Corporation 12957 0.14
Wells Fargo & Company 11418 0.12
XML Financial, LLC 10334 0.11



Süpervizör İş unvanı Ödeme Doğum yılı
Dr. Lishan Aklog M.D. Chairman & CEO 953.2k 1966 (59 yıllar)
Dr. Brian J. deGuzman M.D. Executive VP, Chief Technology & Compliance Officer 427.6k 1965 (60 yıllar)
Dr. Suman M. Verma M.D., Ph.D. Senior VP of Molecular Genetics & Chief Scientific Officer N/A
Michael Parks Vice President of Investor Relations N/A
Mr. Michael Adam Gordon Executive VP, General Counsel & Secretary 710.5k 1975 (50 yıllar)
Dr. Deepika A. Lakhani Ph.D. Senior VP, Chief Regulatory & Quality Officer N/A
Dr. Victoria T. Lee M.D. Senior VP & Chief Medical Officer N/A
Mr. Shaun M. O'Neill M.B.A. Executive VP & COO 1982 (43 yıl)

Adres: United States, New York. NY, 360 Madison Avenue - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.pavmed.com